Ta Win makes foray into pharma industry, invests RM20.8m in Royce Pharma


From left are Royce Pharma Manufacturing president Zainal Ariff Tan Sri Mahmood and group deputy president Datuk Chandrasekar Suppiah; Deputy Human Resources Minister Awang Hashim Awang Hashim while Ta Win Holdings was presented by its group managing director Datuk Seri Ngu Tieng Ung and executive director Tan Poo Chuan.

KUALA LUMPUR: Ta Win Holdings Bhd’s subsidiary is venturing into the pharmaceutical industry through its RM20.85mil investment in Royce Pharma Manufacturing Sdn Bhd.

It said in a statement on Monday its healthcare arm Ta Win Copper Biohealth Sdn Bhd (TWCB) agreed to acquire a 32.5% stake in Royce Pharma, marking the first investment in the pharmaceutical industry.

Get 30% off with our ads free Premium Plan!

Monthly Plan

RM13.90/month
RM9.73 only

Billed as RM9.73 for the 1st month then RM13.90 thereafters.

Annual Plan

RM12.33/month
RM8.63/month

Billed as RM103.60 for the 1st year then RM148 thereafters.

1 month

Free Trial

For new subscribers only


Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!
   

Next In Business News

Changes in Value Partners board
Elevated valuations seen to affect healthcare stocks
SupportLine
Ecobuilt risks trading suspension
November air passenger traffic up
Vietnam’s nuclear ambitions depend on human resource capacity
Bursa ends first trading day of 2025 on weak note
Foong Mun Kong is new managing partner at KPMG
PTP reaffirms spot as global leader in container terminals
Oil on strong footing in new year on lower US stockpiles

Others Also Read